BioNTech SE

(NASDAQ:BNTX)

Latest On BioNTech SE (BNTX):

Date/Time Type Description Signal Details
2023-05-30 08:37 ESTNewsNext set of COVID boosters to target new Omicron variants – WSJN/A
2023-05-25 15:28 ESTNewsBioNTech readying next COVID shot in line with WHO guidanceN/A
2023-05-23 21:14 ESTNewsCOVID vaccine stocks light up amid fears of new infections in ChinaN/A
2023-05-23 06:23 ESTNewsBioNTech: Able To Tap Into High Medical Need PD-L1 Refractory NSCLC MarketN/A
2023-05-19 18:55 ESTNewsCureVac accelerates COVID patent dispute with Pfizer/BioNTech as court grants motionN/A
2023-05-19 04:29 ESTNewsWHO recommends updating COVID shots to add Omicron XBB.1 variantsN/A
2023-05-18 14:33 ESTNewsWHO recommends updating COVID shots to add XBB.1 variantsN/A
2023-05-15 18:25 ESTNewsLaffont's Coatue Management adds stakes in TSM, UNH and exits AVGO, BNTXN/A
2023-05-12 18:06 ESTNewsBioNTech: Hold Out For More Data (Rating Downgrade)N/A
2023-05-08 18:44 ESTNewsBioNTech beats Q1 top and bottom line estimates; reaffirms FY23 outlookN/A
2023-05-08 18:44 ESTNewsBioNTech SE 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-05 21:54 ESTNewsWHO ends global public health emergency status for COVID-19N/A
2023-05-05 21:54 ESTNewsBioNTech Q1 2023 Earnings PreviewN/A
2023-05-04 20:02 ESTNewsWHO meeting is set to decide whether to end COVID emergencyN/A
2023-05-03 18:43 ESTNewsFentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 yearsN/A
2023-05-02 05:03 ESTNewsU.S. to end COVID vaccine mandates for foreign travelers, others next weekN/A
2023-04-27 00:59 ESTNewsPfizer, BioNTech hit new 52-week lowsN/A
2023-04-20 05:16 ESTNewsCDC endorses second updated COVID jab for seniors, immunocompromisedN/A
2023-04-18 18:20 ESTNewsSecond updated COVID booster dose OKd by FDA for at-risk individualsN/A
2023-04-11 22:12 ESTNewsBiden signs bill to end COVID national emergencyN/A
2023-04-05 00:38 ESTNewsPfizer, BioNTech dip as Arbutus charges violation of COVID vaccine patentsN/A
2023-04-03 14:21 ESTNewsBioNTech to pay $170M upfront in license deal for 2 cancer drug assetsN/A
2023-03-28 15:53 ESTNewsBioNTech launches new $0.5B ADS repurchase programN/A
2023-03-28 15:53 ESTNewsBioNTech: A Cheap Large-Cap Pharma With Growth DriversN/A
2023-03-28 15:52 ESTNewsWHO updates COVID vaccine guidance; low priority for children and adolescentsN/A
2023-03-28 00:31 ESTNewsBioNTech SE (BNTX) Q4 2022 Earnings Call TranscriptN/A
2023-03-28 00:31 ESTNewsBioNTech FY22 Earnings Review - 5 Questions Answered After Today's ResultsN/A
2023-03-27 09:02 ESTNewsBioNTech GAAP EPS of €9.26 beats by €1.51, revenue of €4.28B beats by €420MN/A
2023-03-27 09:02 ESTNewsBioNTech projects €5B revenue from Pfizer-partnered COVID shot this yearN/A
2023-03-27 09:02 ESTNewsBioNTech SE 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-24 20:21 ESTNewsBioNTech Q4 2022 Earnings PreviewN/A
2023-03-22 05:23 ESTNewsBiden signs bill to declassify COVID origins informationN/A
2023-03-21 13:59 ESTNewsModerna eyes ~$130 price tag for COVID vaccine shot in US - reportN/A
2023-03-21 13:59 ESTNewsFDA may authorize another round of COVID booster shots - WSJN/A
2023-03-20 23:02 ESTNewsBioNTech licenses solid tumor candidate from OncoC4N/A
2023-03-15 05:32 ESTNewsPfizer faces resistance in plans to modify EU COVID vaccine deal - FTN/A
2023-03-15 05:32 ESTNewsPfizer/BioNTech updated booster cleared in U.S. for childrenN/A
2023-03-08 04:15 ESTNewsU.K. announces spring COVID booster program for at-risk individualsN/A
2023-03-06 22:57 ESTNewsCOVID bivalent vaccine protection can wane after two months - studyN/A
2023-03-03 15:49 ESTNewsCOVID cases continue decline across the US though immune evasive Omicron variant dominatesN/A
2023-03-03 15:49 ESTNewsFlu and COVID combo shots won't roll out this year, top FDA official saysN/A
2023-03-02 10:43 ESTNewsBuy BioNTech For Multiple Catalysts In 2023N/A
2023-03-01 20:18 ESTNewsFBI Director says novel coronavirus likely originated from China lab leakN/A
2023-03-01 20:18 ESTNewsBioNTech to set up mRNA Excellence Center in Israel for research with Weizmann InstituteN/A
2023-03-01 20:18 ESTNewsPfizer/BioNTech seek U.S. emergency nod for updated COVID booster in kidsN/A
2023-02-24 12:11 ESTNewsPfizer, BioNTech seek FDA full approval for Omicron shotN/A
2023-02-19 01:28 ESTNewsCOVID vaccine sales to see decline through end of decade as pandemic easesN/A
2023-02-16 22:02 ESTNewsPfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent disputeN/A
2023-02-13 02:13 ESTNewsCOVID-19 emergency is ending; What it means for free vaccines and drugsN/A
2023-02-10 21:54 ESTNewsPfizer, BioNTech start trial for first mRNA-based shingles vaccineN/A

About BioNTech SE (BNTX):

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/II trial for prostate cancer; BNT113, which is in Phase I trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116, which is in preclinical trail for non-small cell lung cancer. It also develops neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Eli Lilly and Company; Bayer AG; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc.; and InstaDeep Ltd. The company was founded in 2008 and is headquartered in Mainz, Germany.

See Advanced Chart

General

  • Name BioNTech SE
  • Symbol BNTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 1,800
  • Fiscal Year EndDecember
  • IPO Date2019-10-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.biontech.de
View More

Valuation

  • Forward PE 6.8
  • Price/Sales (Trailing 12 Mt.) 130.63
  • Price/Book (Most Recent Quarter) 23.22
  • Enterprise Value Revenue 149.76
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate $0.77
  • Profit Margin -249%
  • Return on Assets -22%
  • Return on Equity -61%
  • Earnings Per Share -$0.56
  • Revenue Per Share $0
  • Gross Profit 91.23 million
  • Quarterly Earnings Growth 135.4%
View More

Highlights

  • Market Capitalization 25.13 billion
  • PE Ratio -40.47
  • Analyst Target Price $119.76
View More

Share Statistics

  • Shares Outstanding 240.79 million
  • Shares Float 75.8 million
  • % Held by Insiders 118%
  • % Held by Institutions 10.51%
  • Shares Short 3.63 million
  • Shares Short Prior Month 3.7 million
  • Short Ratio 1.88
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $131
  • 52 Week Low $37
  • 50 Day Moving Average 109.84
  • 200 Day Moving Average 96.05
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BioNTech SE (BNTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BioNTech SE (BNTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-10$67.46 million-$1.04-$0.47-119.27%
2020-06-302020-08-11$N/A-$0.45-$0.37-20.45%
2020-03-312020-05-12$27.66 million-$0.26-$0.3013.29%
2019-12-312020-03-31$N/A-$0.29-$0.19-51.35%
2019-09-302019-11-14$31.24 million-$0.15-$0.1919.47%

BioNTech SE (BNTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BioNTech SE (BNTX) Chart:

BioNTech SE (BNTX) News:

Below you will find a list of latest news for BioNTech SE (BNTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BioNTech SE (BNTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-17600CALL0 2151.35TRUE00
2026-07-17650CALL0 0130.16TRUE00
2026-07-17700CALL0 0107.75TRUE00
2026-07-17750CALL0 191.43TRUE00
2026-07-1777.50CALL0 282.3TRUE00
2026-07-17800CALL0 073.33TRUE00
2026-07-1782.50CALL0 064.46TRUE00
2026-07-178512.7CALL1 1758.57TRUE12.70
2026-07-1787.50CALL0 7248.17TRUE00
2026-07-17900CALL0 20943.41TRUE00
2026-07-1792.55.05CALL5 26544.94TRUE5.050
2026-07-17954.2CALL20 10545.07TRUE1.80.75
2026-07-1797.53.21CALL14 105347.61TRUE1.841.34
2026-07-171001.98CALL219 46036.99FALSE1.121.3
2026-07-171050.8CALL9 19636.94FALSE0.451.29
2026-07-171100.29CALL239 49742.36FALSE0.191.9
2026-07-171150.19CALL5 4943.34FALSE0.190
2026-07-171200.07CALL7 2547.11FALSE0.010.17
2026-07-171250CALL0 276.37FALSE00
2026-07-171300CALL0 0108.56FALSE00
2026-07-171350CALL0 0118.34FALSE00
2026-07-171400CALL0 0127.53FALSE00
2026-07-17600.05PUT0 11175.19FALSE00
2026-07-17650.05PUT30 5298.06FALSE-0.01-0.17
2026-07-17700.23PUT0 992.62FALSE00
2026-07-17750PUT0 58107.97FALSE00
2026-07-1777.50PUT0 7397.7FALSE00
2026-07-17800.05PUT1 13548.29FALSE0.050
2026-07-1782.50PUT0 14541.7FALSE00
2026-07-17850PUT0 137137.02FALSE00
2026-07-1787.50.45PUT15 94532.89FALSE-0.25-0.36
2026-07-17900.5PUT3 156629.95FALSE-1.3-0.72
2026-07-1792.51.15PUT3 32040.91FALSE-1.13-0.5
2026-07-17951.47PUT12 6535.65FALSE1.470
2026-07-1797.52.91PUT5 17532.5FALSE2.910
2026-07-171003.88PUT3 2334.38TRUE-3.47-0.47
2026-07-171050PUT0 830.69TRUE00
2026-07-171100PUT0 041.84TRUE00
2026-07-171150PUT0 046.02TRUE00
2026-07-171200PUT0 052.04TRUE00
2026-07-171250PUT0 060.95TRUE00
2026-07-171300PUT0 00TRUE00
2026-07-171350PUT0 00TRUE00
2026-07-171400PUT0 00TRUE00
2026-08-21600CALL0 098.99TRUE00
2026-08-21650CALL0 087.81TRUE00
2026-08-21700CALL0 076.9TRUE00
2026-08-21750CALL0 066.9TRUE00
2026-08-21800CALL0 059.13TRUE00
2026-08-2182.50CALL0 058.88TRUE00
2026-08-21850CALL0 054.17TRUE00
2026-08-2187.50CALL0 052.69TRUE00
2026-08-21900CALL0 251.94TRUE00
2026-08-2192.50CALL0 050.94TRUE00
2026-08-21957.9CALL6 848.63TRUE7.90
2026-08-2197.56.83CALL23 15749.27TRUE2.030.42
2026-08-211005.45CALL11 14050.3FALSE1.450.36
2026-08-211053.2CALL73 2749.44FALSE0.70.28
2026-08-211102.33CALL532 10843.26FALSE0.580.33
2026-08-211151.72CALL4 142.75FALSE1.720
2026-08-211201.1CALL2 17744.99FALSE0.450.69
2026-08-211250CALL0 050.47FALSE00
2026-08-211300CALL0 263.48FALSE00
2026-08-211350CALL0 068.23FALSE00
2026-08-21600PUT0 085.63FALSE00
2026-08-21650.1PUT15 067.44FALSE0.10
2026-08-21700.75PUT1 556.83FALSE00
2026-08-21750PUT0 155.95FALSE00
2026-08-21800.85PUT49 25541.91FALSE-0.3-0.26
2026-08-2182.52.45PUT0 10343.43FALSE00
2026-08-21851.77PUT48 1839.14FALSE-0.68-0.28
2026-08-2187.53.23PUT0 36544.33FALSE00
2026-08-21900PUT0 9940.83FALSE00
2026-08-2192.50PUT0 841.89FALSE00
2026-08-21954.9PUT1 439.82FALSE4.90
2026-08-2197.50PUT0 039.1FALSE00
2026-08-211007.4PUT1 637.86TRUE7.40
2026-08-2110513.7PUT0 6536.29TRUE00
2026-08-211100PUT0 033.88TRUE00
2026-08-211150PUT0 034.26TRUE00
2026-08-211200PUT0 00TRUE00
2026-08-211250PUT0 00TRUE00
2026-08-211300PUT0 00TRUE00
2026-08-211350PUT0 00TRUE00
2026-09-18500CALL0 2111.77TRUE00
2026-09-18550CALL0 0100.4TRUE00
2026-09-18600CALL0 089.64TRUE00
2026-09-18650CALL0 1879.33TRUE00
2026-09-18700CALL0 171.29TRUE00
2026-09-18750CALL0 264.49TRUE00
2026-09-1877.50CALL0 061.25TRUE00
2026-09-188020.2CALL1 2256.93TRUE20.20
2026-09-1882.50CALL0 055.29TRUE00
2026-09-188515.79CALL1 4353.1TRUE15.790
2026-09-1887.50CALL0 33053.07TRUE00
2026-09-189011.97CALL5 27553.25TRUE2.570.27
2026-09-1892.511.41CALL9 3052.4TRUE11.410
2026-09-18959CALL1 12252.1TRUE90
2026-09-1897.50CALL0 24349.45TRUE00
2026-09-181006.63CALL47 62048.18FALSE6.630
2026-09-181050CALL0 109949.25FALSE00
2026-09-181103.8CALL60 217146.77FALSE1.450.62
2026-09-181150CALL0 63142.81FALSE00
2026-09-181201.8CALL57 75846.55FALSE1.80
2026-09-181250.9CALL0 21045.05FALSE00
2026-09-181300.9CALL2 17849.03FALSE0.90
2026-09-181350CALL0 6749.56FALSE00
2026-09-181400.45CALL0 28745.54FALSE00
2026-09-181450CALL0 752.66FALSE00
2026-09-181500CALL0 5050.63FALSE00
2026-09-181550CALL0 28057.44FALSE00
2026-09-181600CALL0 18354.78FALSE00
2026-09-181650CALL0 953.31FALSE00
2026-09-181700CALL0 163.21FALSE00
2026-09-181750CALL0 255.08FALSE00
2026-09-181800CALL0 057.24FALSE00
2026-09-181850CALL0 1657.33FALSE00
2026-09-18500PUT0 098.94FALSE00
2026-09-18550PUT0 105355.56FALSE00
2026-09-18600.15PUT2 1047.7FALSE0.150
2026-09-18650.24PUT10 5045.18FALSE0.240
2026-09-18700PUT0 67444.86FALSE00
2026-09-18750PUT0 19836.77FALSE00
2026-09-1877.50PUT0 15836.31FALSE00
2026-09-18801.4PUT10 280344.41FALSE1.40
2026-09-1882.50PUT0 23336.53FALSE00
2026-09-18852.4PUT1 57933.21FALSE-0.6-0.2
2026-09-1887.50PUT0 114733.23FALSE00
2026-09-18903.88PUT3 62533.02FALSE-0.87-0.18
2026-09-1892.56.45PUT0 10632.58FALSE00
2026-09-18956.1PUT2 42337.36FALSE-1.65-0.21
2026-09-1897.50PUT0 121832.23FALSE00
2026-09-181000PUT0 51836.83TRUE00
2026-09-1810514.6PUT0 55935.95TRUE00
2026-09-181100PUT0 7731.48TRUE00
2026-09-181150PUT0 2426.01TRUE00
2026-09-181200PUT0 520TRUE00
2026-09-181250PUT0 00TRUE00
2026-09-181300PUT0 100TRUE00
2026-09-181350PUT0 00TRUE00
2026-09-181400PUT0 00TRUE00
2026-09-181450PUT0 00TRUE00
2026-09-181500PUT0 00TRUE00
2026-09-181550PUT0 00TRUE00
2026-09-181600PUT0 00TRUE00
2026-09-181650PUT0 00TRUE00
2026-09-181700PUT0 00TRUE00
2026-09-181750PUT0 00TRUE00
2026-09-181800PUT0 00TRUE00
2026-09-181850PUT0 00TRUE00
2026-12-18450CALL0 0107.09TRUE00
2026-12-1847.50CALL0 0101.47TRUE00
2026-12-18500CALL0 096.69TRUE00
2026-12-18550CALL0 088.59TRUE00
2026-12-18600CALL0 081.12TRUE00
2026-12-18650CALL0 075.24TRUE00
2026-12-18700CALL0 069.79TRUE00
2026-12-18750CALL0 066.07TRUE00
2026-12-1877.50CALL0 064.33TRUE00
2026-12-188019.64CALL0 763.14TRUE00
2026-12-1882.50CALL0 062.39TRUE00
2026-12-18850CALL0 060.88TRUE00
2026-12-1887.50CALL0 059.79TRUE00
2026-12-18900CALL0 558.66TRUE00
2026-12-1892.50CALL0 057.5TRUE00
2026-12-18950CALL0 1357.48TRUE00
2026-12-1897.50CALL0 057TRUE00
2026-12-181009.3CALL0 1455.65FALSE00
2026-12-181059.6CALL2 455.19FALSE9.60
2026-12-181106.5CALL0 2754.16FALSE00
2026-12-181150CALL0 353.44FALSE00
2026-12-181204.1CALL0 7852.47FALSE00
2026-12-181250CALL0 17550.82FALSE00
2026-12-181300CALL0 350.23FALSE00
2026-12-181350CALL0 1050.56FALSE00
2026-12-181400CALL0 1550.28FALSE00
2026-12-181450CALL0 051.11FALSE00
2026-12-181500CALL0 1246.73FALSE00
2026-12-181550CALL0 052.39FALSE00
2026-12-181600CALL0 1047.28FALSE00
2026-12-18450PUT0 069.71FALSE00
2026-12-1847.50PUT0 063.81FALSE00
2026-12-18500PUT0 061.89FALSE00
2026-12-18550PUT0 460.1FALSE00
2026-12-18600.94PUT2 2249.48FALSE0.940
2026-12-18650PUT0 1547.35FALSE00
2026-12-18700PUT0 345.88FALSE00
2026-12-18750PUT0 3739.11FALSE00
2026-12-1877.50PUT0 040.05FALSE00
2026-12-18800PUT0 3440.57FALSE00
2026-12-1882.50PUT0 139.2FALSE00
2026-12-18850PUT0 239.68FALSE00
2026-12-1887.50PUT0 238.59FALSE00
2026-12-18907.5PUT1 738.6FALSE7.50
2026-12-1892.50PUT0 2037.58FALSE00
2026-12-18950PUT0 637.79FALSE00
2026-12-1897.50PUT0 036.8FALSE00
2026-12-1810014.4PUT0 536.43TRUE00
2026-12-181050PUT0 234.28TRUE00
2026-12-181100PUT0 131.81TRUE00
2026-12-181150PUT0 130TRUE00
2026-12-1812029.5PUT0 323.93TRUE00
2026-12-181250PUT0 00TRUE00
2026-12-181300PUT0 00TRUE00
2026-12-181350PUT0 00TRUE00
2026-12-181400PUT0 00TRUE00
2026-12-181450PUT0 00TRUE00
2026-12-181500PUT0 00TRUE00
2026-12-181550PUT0 00TRUE00
2026-12-181600PUT0 00TRUE00
2027-01-1542.50CALL0 0108.82TRUE00
2027-01-15450CALL0 1103.67TRUE00
2027-01-1547.50CALL0 098.21TRUE00
2027-01-15500CALL0 095.04TRUE00
2027-01-15550CALL0 286.86TRUE00
2027-01-15600CALL0 780.48TRUE00
2027-01-15650CALL0 374.71TRUE00
2027-01-15700CALL0 13570.52TRUE00
2027-01-15750CALL0 6366.9TRUE00
2027-01-1577.50CALL0 3364.75TRUE00
2027-01-158020.7CALL0 27063.61TRUE00
2027-01-1582.50CALL0 762.69TRUE00
2027-01-15850CALL0 7662.12TRUE00
2027-01-1587.50CALL0 461.11TRUE00
2027-01-159018CALL2 12859.88TRUE180
2027-01-1592.516.15CALL1 4459.61TRUE1.870.13
2027-01-159514.74CALL1 1858.52TRUE14.740
2027-01-1597.50CALL0 758.35TRUE00
2027-01-151000CALL0 8555.55FALSE00
2027-01-151050CALL0 7655.98FALSE00
2027-01-151108.7CALL14 16655.78FALSE8.70
2027-01-151150CALL0 40355.03FALSE00
2027-01-151205CALL8 51352.52FALSE50
2027-01-151255.05CALL1 165153.13FALSE0.50.11
2027-01-151300CALL0 5854.09FALSE00
2027-01-151350CALL0 3253.67FALSE00
2027-01-151403CALL2 13453.69FALSE30
2027-01-151450CALL0 16450.17FALSE00
2027-01-151502.03CALL1 36349.93FALSE2.030
2027-01-151550CALL0 3450.85FALSE00
2027-01-151600CALL0 4446.28FALSE00
2027-01-151650CALL0 2350.61FALSE00
2027-01-151700CALL0 1851.34FALSE00
2027-01-151750.9CALL1 100355.5FALSE0.90
2027-01-151800CALL0 9153.86FALSE00
2027-01-151850CALL0 14760.13FALSE00
2027-01-1542.50PUT0 2363.9FALSE00
2027-01-15450PUT0 759.23FALSE00
2027-01-1547.50PUT0 666.67FALSE00
2027-01-15500PUT0 2558.91FALSE00
2027-01-15550PUT0 7747.74FALSE00
2027-01-15600PUT0 13946.03FALSE00
2027-01-15650PUT0 6440.77FALSE00
2027-01-15700PUT0 24641.89FALSE00
2027-01-15750PUT0 7239.77FALSE00
2027-01-1577.50PUT0 22641.58FALSE00
2027-01-15800PUT0 13239.29FALSE00
2027-01-1582.50PUT0 3539.07FALSE00
2027-01-15850PUT0 9138.87FALSE00
2027-01-1587.50PUT0 1138.3FALSE00
2027-01-15909PUT1 87537.77FALSE90
2027-01-1592.59.7PUT1 837.66FALSE9.70
2027-01-15950PUT0 18337.57FALSE00
2027-01-1597.50PUT0 19036.4FALSE00
2027-01-151000PUT0 14336.01TRUE00
2027-01-151050PUT0 4834.59TRUE00
2027-01-1511022.12PUT0 4031.17TRUE00
2027-01-151150PUT0 3429.97TRUE00
2027-01-151200PUT0 22026.99TRUE00
2027-01-151250PUT0 200TRUE00
2027-01-151300PUT0 90TRUE00
2027-01-151350PUT0 110TRUE00
2027-01-151400PUT0 110TRUE00
2027-01-151450PUT0 00TRUE00
2027-01-151500PUT0 90TRUE00
2027-01-151550PUT0 00TRUE00
2027-01-151600PUT0 00TRUE00
2027-01-151650PUT0 00TRUE00
2027-01-151700PUT0 00TRUE00
2027-01-151750PUT0 00TRUE00
2027-01-151800PUT0 00TRUE00
2027-01-151850PUT0 00TRUE00
2028-01-21450CALL0 0101.67TRUE00
2028-01-2147.50CALL0 198.56TRUE00
2028-01-21500CALL0 39495.54TRUE00
2028-01-21550CALL0 091.66TRUE00
2028-01-21600CALL0 1087.62TRUE00
2028-01-21650CALL0 383.6TRUE00
2028-01-21700CALL0 1681.22TRUE00
2028-01-21750CALL0 278.54TRUE00
2028-01-2177.50CALL0 477.08TRUE00
2028-01-218034CALL1 15276.29TRUE2.90.09
2028-01-2182.50CALL0 275.44TRUE00
2028-01-218532CALL1 53274.53TRUE320
2028-01-2187.50CALL0 1673.58TRUE00
2028-01-21900CALL0 3773.22TRUE00
2028-01-2192.50CALL0 3972.16TRUE00
2028-01-21950CALL0 10271.03TRUE00
2028-01-2197.50CALL0 9470.48TRUE00
2028-01-211000CALL0 12269.86FALSE00
2028-01-211050CALL0 1968.45FALSE00
2028-01-211100CALL0 13768.02FALSE00
2028-01-211150CALL0 11666.79FALSE00
2028-01-2112018.65CALL12 16263.02FALSE18.650
2028-01-211250CALL0 8963.16FALSE00
2028-01-211300CALL0 1664.29FALSE00
2028-01-211350CALL0 764.08FALSE00
2028-01-211400CALL0 8062.51FALSE00
2028-01-211450CALL0 4861.98FALSE00
2028-01-211500CALL0 10462.53FALSE00
2028-01-211550CALL0 361.72FALSE00
2028-01-211600CALL0 1460.75FALSE00
2028-01-211650CALL0 260.95FALSE00
2028-01-211700CALL0 461.05FALSE00
2028-01-211750CALL0 261.05FALSE00
2028-01-211800CALL0 260.97FALSE00
2028-01-211856.8CALL1 3159.49FALSE6.80
2028-01-21450PUT0 2449.15FALSE00
2028-01-2147.50PUT0 445.29FALSE00
2028-01-21500PUT0 2845.01FALSE00
2028-01-21550PUT0 143.7FALSE00
2028-01-21600PUT0 1941.74FALSE00
2028-01-21650PUT0 1041.05FALSE00
2028-01-21700PUT0 1339.67FALSE00
2028-01-21750PUT0 28239.19FALSE00
2028-01-2177.50PUT0 1338.71FALSE00
2028-01-21800PUT0 735.02FALSE00
2028-01-2182.50PUT0 637.34FALSE00
2028-01-21850PUT0 336.47FALSE00
2028-01-2187.50PUT0 136.74FALSE00
2028-01-21900PUT0 1035.61FALSE00
2028-01-2192.50PUT0 1635.61FALSE00
2028-01-21950PUT0 1734.23FALSE00
2028-01-2197.50PUT0 433.96FALSE00
2028-01-211000PUT0 1733.57TRUE00
2028-01-211050PUT0 632.39TRUE00
2028-01-211100PUT0 1630.64TRUE00
2028-01-2111533.14PUT0 7928.16TRUE00
2028-01-211200PUT0 1726.34TRUE00
2028-01-211250PUT0 1023.32TRUE00
2028-01-211300PUT0 815.69TRUE00
2028-01-211350PUT0 00TRUE00
2028-01-211400PUT0 00TRUE00
2028-01-211450PUT0 00TRUE00
2028-01-211500PUT0 00TRUE00
2028-01-211550PUT0 00TRUE00
2028-01-211600PUT0 00TRUE00
2028-01-211650PUT0 00TRUE00
2028-01-211700PUT0 00TRUE00
2028-01-211750PUT0 00TRUE00
2028-01-211800PUT0 00TRUE00
2028-01-211850PUT0 00TRUE00

Latest BNTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$133.565
Jun 13, 2022 7:59 PM EST50$133.6
Jun 13, 2022 7:59 PM EST25$133.58
Jun 13, 2022 7:59 PM EST100$133.58
Jun 13, 2022 7:59 PM EST9$133.59

BioNTech SE (BNTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020031413/0001564590-20-031413-index.htm
2019-07-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1776985/000000000019011190/0000000000-19-011190-index.htm
2019-08-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1776985/000000000019012664/0000000000-19-012664-index.htm
2019-09-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1776985/000000000019013788/0000000000-19-013788-index.htm
2020-01-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1776985/000000000020000758/0000000000-20-000758-index.htm
2020-02-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1776985/000000000020001683/0000000000-20-001683-index.htm
2019-06-19DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012319006061/0000950123-19-006061-index.htm
2019-08-05DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012319006987/0000950123-19-006987-index.htm
2019-08-05DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012319006989/0000950123-19-006989-index.htm
2020-01-27DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012320000526/0000950123-20-000526-index.htm
2020-02-20DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012320002647/0000950123-20-002647-index.htm
2020-02-20DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012320002649/0000950123-20-002649-index.htm
2020-06-12DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012320006236/0000950123-20-006236-index.htm
2020-06-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1776985/000095012320006237/0000950123-20-006237-index.htm
2019-09-09F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312519241112/0001193125-19-241112-index.htm
2019-09-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312519241118/0001193125-19-241118-index.htm
2019-09-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312519249456/0001193125-19-249456-index.htm
2019-09-24F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312519252726/0001193125-19-252726-index.htm
2019-09-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312519252734/0001193125-19-252734-index.htm
2019-10-04F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312519262865/0001193125-19-262865-index.htm
2019-10-078-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1776985/000119312519263738/0001193125-19-263738-index.htm
2019-10-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312519263740/0001193125-19-263740-index.htm
2019-10-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312519263741/0001193125-19-263741-index.htm
2019-10-09F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312519264798/0001193125-19-264798-index.htm
2019-10-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1776985/000119312519265455/0001193125-19-265455-index.htm
2019-10-11424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1776985/000119312519266733/0001193125-19-266733-index.htm
2020-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520008535/0001193125-20-008535-index.htm
2020-01-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520008540/0001193125-20-008540-index.htm
2020-01-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520009100/0001193125-20-009100-index.htm
2020-01-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1776985/000119312520013079/0001193125-20-013079-index.htm
2020-01-23425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520013082/0001193125-20-013082-index.htm
2020-02-03F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312520022991/0001193125-20-022991-index.htm
2020-02-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312520023027/0001193125-20-023027-index.htm
2020-02-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312520023031/0001193125-20-023031-index.htm
2020-02-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520023078/0001193125-20-023078-index.htm
2020-02-07RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1776985/000119312520028130/0001193125-20-028130-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520033238/0001193125-20-033238-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520035059/0001193125-20-035059-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520037724/0001193125-20-037724-index.htm
2020-04-01F-4Registration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/0001193125-20-092985-index.htm
2020-03-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1776985/000119312520093026/0001193125-20-093026-index.htm
2020-04-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520096022/0001193125-20-096022-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520134949/0001193125-20-134949-index.htm
2020-07-21F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312520195911/0001193125-20-195911-index.htm
2020-07-21F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312520195916/0001193125-20-195916-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520196456/0001193125-20-196456-index.htm
2020-07-22FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520196544/0001193125-20-196544-index.htm
2020-07-22FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1776985/000119312520196547/0001193125-20-196547-index.htm
2020-07-22F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312520196813/0001193125-20-196813-index.htm
2020-07-22F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520197246/0001193125-20-197246-index.htm
2020-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520197411/0001193125-20-197411-index.htm
2020-07-23F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1776985/000119312520197867/0001193125-20-197867-index.htm
2020-07-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520198614/0001193125-20-198614-index.htm
2020-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520199727/0001193125-20-199727-index.htm
2020-07-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520200536/0001193125-20-200536-index.htm
2020-07-31424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520206682/0001193125-20-206682-index.htm
2020-08-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520210694/0001193125-20-210694-index.htm
2020-08-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520216473/0001193125-20-216473-index.htm
2020-08-12424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520217787/0001193125-20-217787-index.htm
2020-08-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000119312520223699/0001193125-20-223699-index.htm
2020-08-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520227130/0001193125-20-227130-index.htm
2020-08-27424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1776985/000119312520233282/0001193125-20-233282-index.htm
2020-09-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1776985/000120919120050787/0001209191-20-050787-index.htm
2019-10-09CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1776985/000135445719000507/0001354457-19-000507-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459019043367/0001564590-19-043367-index.htm
2019-12-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459019046132/0001564590-19-046132-index.htm
2020-01-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020000126/0001564590-20-000126-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020000897/0001564590-20-000897-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020000933/0001564590-20-000933-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020001140/0001564590-20-001140-index.htm
2020-01-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020002074/0001564590-20-002074-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020010979/0001564590-20-010979-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020010980/0001564590-20-010980-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020011287/0001564590-20-011287-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020014377/0001564590-20-014377-index.htm
2020-03-31425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000156459020014382/0001564590-20-014382-index.htm
2020-03-31425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000156459020014533/0001564590-20-014533-index.htm
2020-03-3120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1776985/000156459020014536/0001564590-20-014536-index.htm
2020-03-31425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1776985/000156459020014579/0001564590-20-014579-index.htm
2020-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020016001/0001564590-20-016001-index.htm
2020-04-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020017808/0001564590-20-017808-index.htm
2020-04-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020017810/0001564590-20-017810-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020019419/0001564590-20-019419-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020020990/0001564590-20-020990-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020024741/0001564590-20-024741-index.htm
2020-06-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020028940/0001564590-20-028940-index.htm
2020-06-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020030169/0001564590-20-030169-index.htm
2020-06-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020030175/0001564590-20-030175-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020030780/0001564590-20-030780-index.htm
2020-06-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020030913/0001564590-20-030913-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020031413/0001564590-20-031413-index.htm
2020-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020032206/0001564590-20-032206-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020032665/0001564590-20-032665-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020032688/0001564590-20-032688-index.htm
2020-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020033078/0001564590-20-033078-index.htm
2020-07-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020033641/0001564590-20-033641-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020034491/0001564590-20-034491-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020034493/0001564590-20-034493-index.htm
2020-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020035028/0001564590-20-035028-index.htm
2020-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020035029/0001564590-20-035029-index.htm
2020-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020036408/0001564590-20-036408-index.htm
2020-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020036468/0001564590-20-036468-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020039114/0001564590-20-039114-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020039472/0001564590-20-039472-index.htm
2020-08-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020040845/0001564590-20-040845-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020042855/0001564590-20-042855-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020042868/0001564590-20-042868-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020043341/0001564590-20-043341-index.htm
2020-09-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020043476/0001564590-20-043476-index.htm
2020-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020043767/0001564590-20-043767-index.htm
2020-10-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020045848/0001564590-20-045848-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1776985/000156459020046587/0001564590-20-046587-index.htm
2019-10-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1776985/999999999519002281/9999999995-19-002281-index.htm
2020-02-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1776985/999999999520000265/9999999995-20-000265-index.htm
2020-04-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1776985/999999999520000676/9999999995-20-000676-index.htm
2020-07-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1776985/999999999520001891/9999999995-20-001891-index.htm
2020-07-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1776985/999999999520001920/9999999995-20-001920-index.htm
2019-07-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1776985/999999999719006083/9999999997-19-006083-index.htm
2019-09-30SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1776985/999999999719007167/9999999997-19-007167-index.htm
2020-01-29SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1776985/999999999720000340/9999999997-20-000340-index.htm
2020-01-29SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1776985/999999999720000341/9999999997-20-000341-index.htm